1. Home
  2. BN vs BMY Comparison

BN vs BMY Comparison

Compare BN & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Corporation Limited Voting Shares

BN

Brookfield Corporation Limited Voting Shares

HOLD

Current Price

$44.66

Market Cap

108.6B

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$63.94

Market Cap

113.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BN
BMY
Founded
1997
1887
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.6B
113.5B
IPO Year
1998
2006

Fundamental Metrics

Financial Performance
Metric
BN
BMY
Price
$44.66
$63.94
Analyst Decision
Strong Buy
Buy
Analyst Count
7
15
Target Price
$49.87
$61.73
AVG Volume (30 Days)
4.1M
12.3M
Earning Date
05-14-2026
04-30-2026
Dividend Yield
0.58%
4.38%
EPS Growth
N/A
178.46
EPS
N/A
2.93
Revenue
N/A
$48,194,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.74
N/A
P/E Ratio
$93.92
$21.71
Revenue Growth
N/A
N/A
52 Week Low
$37.93
$42.52
52 Week High
$74.20
$68.10

Technical Indicators

Market Signals
Indicator
BN
BMY
Relative Strength Index (RSI) 58.52 58.10
Support Level $43.79 $56.46
Resistance Level $44.70 $68.10
Average True Range (ATR) 0.93 1.81
MACD 0.28 -0.18
Stochastic Oscillator 76.74 34.08

Price Performance

Historical Comparison
BN
BMY

About BN Brookfield Corporation Limited Voting Shares

Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals, operating through seven segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity (which generates the highest revenue), Real Estate, and Corporate Activities. The company invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders, with the majority of its revenue coming from Asset Management. It has a presence across the United Kingdom, the United States (which contributes the highest revenue), Australia, Canada, Brazil, India, Colombia, Germany, other parts of Europe, other parts of Asia, and additional countries.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: